4D Molecular Therapeutics Inc (FDMT) — Working Capital to Net Assets Ratio
4D Molecular Therapeutics Inc (FDMT) has a Working Capital to Net Assets ratio of 73.0% as of December 2025. Working capital of $369.15 Million (current assets of $413.13 Million minus current liabilities of $43.98 Million) is measured against net assets of $505.66 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See 4D Molecular Therapeutics Inc (FDMT) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
4D Molecular Therapeutics Inc Working Capital to Net Assets (2017–2025)
This chart shows how 4D Molecular Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the ratio stands at 73.0%, reflecting working capital of $369.15 Million against net assets of $505.66 Million USD. For the complete balance sheet picture, see total assets of 4D Molecular Therapeutics Inc.
Annual Working Capital to Net Assets for 4D Molecular Therapeutics Inc (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for 4D Molecular Therapeutics Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of 4D Molecular Therapeutics Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 73.0% | $369.15 Million | $505.66 Million | $413.13 Million | $43.98 Million | ▼ -6.5 pp |
| 2024 | 79.5% | $405.78 Million | $510.61 Million | $434.93 Million | $29.15 Million | ▼ -10.7 pp |
| 2023 | 90.2% | $277.64 Million | $307.83 Million | $296.59 Million | $18.95 Million | ▲ +1.7 pp |
| 2022 | 88.5% | $204.78 Million | $231.34 Million | $220.51 Million | $15.73 Million | ▲ +13.3 pp |
| 2021 | 75.2% | $239.94 Million | $319.11 Million | $256.28 Million | $16.34 Million | ▼ -28.5 pp |
| 2020 | 103.7% | $265.91 Million | $256.39 Million | $282.66 Million | $16.74 Million | ▲ +157.9 pp |
| 2019 | -54.2% | $39.55 Million | $-72.97 Million | $52.51 Million | $12.96 Million | ▲ +257.6 pp |
| 2018 | -311.8% | $86.01 Million | $-27.59 Million | $94.07 Million | $8.05 Million | ▼ -216.9 pp |
| 2017 | -94.9% | $18.59 Million | $-19.59 Million | $24.50 Million | $5.91 Million | — |